Pinsent Masons advises Bryan, Garnier & Co on Heidelberg Pharma AG’s capital increase

28 Jun 2021 | 02:23 pm |

Multinational law firm Pinsent Masons has advised Bryan, Garnier & Co on the successful EUR 20m capital increase of Heidelberg Pharma AG.

The transaction increased German based biopharmaceutical company Heidelberg Pharma AG’s share capital by approximately 10%, with the 3,106,637 newly issued shares offered to qualified institutional investors in Europe and the United States in an accelerated book-building process. At a subscription price of EUR 6.44 per share, the company raised gross proceeds of EUR 20 million.

The new shares were admitted to trading on the Frankfurt Stock Exchange on June 21, 2021.

Pinsent Masons advised Bryan, Garnier & Co, the sole global coordinator and sole bookrunner for the transaction. Bryan, Garnier & Co is one of the most active investment banks in the European growth sector, with a particular focus on healthcare, technology, consumer goods and business services. They are a fully registered broker-dealer, licensed and supervised by the FCA in Europe and FINRA in the US.

The Pinsent Masons team was led by Dr Susanne Lenz, LL.M. and included Roberta Markovina (Partner, London), Dušan Stojković (Senior Associate, Frankfurt) and Sara Šepac (Associate, Frankfurt).

Commenting on the transaction, Dr Susanne Lenz said:

"We are pleased to have worked with Bryan Garnier on this exciting and important transaction. With Heidelberg Pharma AG’s expertise in oncology, we are proud to have been part of the successful financing of a company on the cutting edge of biopharmaceutical research and development in Germany."

Latest press releases

Show me all press releases

Pinsent Masons advises Q ENERGY on the design and drafting of a refurbishment contract for a pioneering and innovative wind farm project based on second-hand turbines in France

Pinsent Masons has advised Q ENERGY on the design and drafting of a refurbishment contract for an innovative wind project in France, relying exclusively on second-hand wind turbines. The project, scheduled for commissioning in 2028, represents a significant step forward in the integration of circular‑economy principles within the renewable energy sector.

Pinsent Masons expands global arbitration offering with strategic partner hire in London

Multinational law firm Pinsent Masons has strengthened its international arbitration practice with the appointment of Cem Kalelioglu as a partner in London, reinforcing the firm's growing presence in high-value investor-state and commercial disputes.

Pinsent Masons advises on Victorian government-owned wind farm project

Multinational law firm Pinsent Masons has advised global wind turbine manufacturer Vestas on its role in the Delburn Wind Farm in the Australian state of Victoria.

People who viewed this press release also viewed

Show me all press releases

Pinsent Masons advises IFC on landmark investment to boost Retail sector in Senegal

Multinational law firm Pinsent Masons has advised International Finance Corporation (IFC), a member of the World Bank Group and the largest global development institution focused on the private sector in emerging markets, on its landmark investment of €25 million in Groupe EDK, Senegal’s foremost retail and large-scale distribution operator.

Pinsent Masons advises Idox plc on takeover by long path partners

Multinational law firm Pinsent Masons has advised on the recommended public takeover of AIM-listed Idox plc (Idox) by Frankel Bidco Limited, a vehicle that is indirectly owned by funds managed by Long Path Partners.

Pinsent Masons advises International Finance Corporation on milestone Bhutan investment

Multinational law firm Pinsent Masons has advised International Finance Corporation (IFC), the largest global development institution focused on the private sector in emerging markets, on its first ever investment in Bhutan’s energy and infrastructure sectors.

For all media enquiries, including arranging an interview with one of our spokespeople, please contact the press office on

+44 (0)20 7418 8199 or 

Location contacts

We are processing your request. \n Thank you for your patience. An error occurred. This could be due to inactivity on the page - please try again.